A 37-year-old patient, with a history of arrhythmogenic right ventricular cardiomyopathy (ARVC) and involvement of the left ventricle, was admitted due to repetitive implantable cardioverter-defibrillator (ICD) shocks and syncope in the course of ventricular tachycardia (VT) and ventricular fibrillation (VF).
A 37-year-old patient, with a history of arrhythmogenic right ventricular cardiomyopathy (ARVC) and involvement of the left ventricle, was admitted due to repetitive implantable cardioverter-defibrillator (ICD) shocks and syncope in the course of ventricular tachycardia (VT) and ventricular fibrillation (VF).
He had previously experienced multiple appropriate therapies for VT, and had undergone endocardial/epicardial ablation procedures with a temporary reduction of arrhythmia burden. He had been previously implanted with an ICD (dualcoil passive-fixation lead). Prior treatment with sotalol and amiodarone was not successful.
Implantable cardioverter-defibrillator interrogation showed intermittent under-sensing of VT and VF, which lead to a delay in therapy. R-wave amplitude during sinus rhythm was 2-3 mV.
The initial plan of treatment was to exchange the right ventricular (RV) ICD lead, in order to achieve appropriate R-wave amplitude and sensing. After reviewing voltage maps from previous ablation procedures -RV voltage maps showed RV potentials of over 4 mV only in the area around the His bundle, with the rest of the RV being scarred.
Epicardial maps showed higher potential amplitude only over the lateral and posterior basal surface of the left ventricle. Therefore it was decided to implant an epicardial sensing lead in the region with sufficient signal amplitude. An epicardial lead was implanted from left micro-thoracotomy approach (R-wave amplitude 20 mV, threshold 0.8V/0.4 ms, impedance 800 Ohm) and connected instead of the endocardial pace-sense channel, together with highvoltage channels of the previously implanted lead, to the ICD (Fig. 1) . During follow-up, the patient experienced VT and VF episodes that were appropriately detected and treated with antytachycardia pacing or shocks. This approach has proven feasible, when the conventional ICD system cannot be applied.
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